Galileo Life Sciences, Inc. Debt Conversion, Converted Instrument, Amount
Galileo Life Sciences, Inc. reported Debt Conversion, Converted Instrument, Amount of $727.72 thousand for the 9-month period ending 2015-03-31, per its 10-Q filed 2016-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-04-01
- Galileo Life Sciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2015-03-31 was $276.92K.
- Galileo Life Sciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-03-31 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month |
|---|---|---|---|
| 2015-03-31 | $276.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-01 | $727.72K 10-Q · filed 2016-04-01 | |
| 2014-12-31 | $450.80K 10-Q · filed 2016-02-22 | ||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-01 | $0.00 10-Q · filed 2016-04-01 | |
| 2013-12-31 | $0.00 10-Q · filed 2016-02-22 |